Sign inJoin waitlistJoin the waitlist

Hugo Vargas

Director, Research Curriculum · Mayo Clinic College of Medicine and Science

Credentials: · · · · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present
research · Mayo Clinic Alix School of Medicine
2016–Present
Clinical Research Subcommittee Department · Arizona Research Operations Management Team
2016–Present

Transplant Hepatology
1997–1998
Gastroenterology
UPMC
1994–1997
Internal Medicine University of Utah Affiliated Hospitals
1991–1994
- Doctor of Medicine Hahnemann University Graduate School of Medicine
1987–1991
Hahnemann University Graduate School
1989
University of California, Davis
1986

Research

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Gastroenterology · 2015 · 647 citations
An interferon-free antiviral regimen for HCV after liver transplantation
New England Journal of Medicine · 2014 · 338 citations
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
New England Journal of Medicine · 2018 · 334 citations

JR
Jorge Rakela
68 papers
JB
Jasmohan Bajaj
33 papers
KR
Kuchikula Reddy
33 papers
Patrick Kamath
30 papers
Jacqueline O'Leary
28 papers
Thomas Byrne
28 papers · 5 as a fellow
David Douglas
27 papers
GG
Guadalupe Garcia-Tsao
27 papers
Jennifer Lai
26 papers · 11 as a fellow
Scott Biggins
25 papers · 1 as a fellow
PT
Paul Thuluvath
24 papers
Bashar Aqel
23 papers

Grants

HCV Quasispecies Dynamics and Liver Transplant
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $471K · Mayo Clinic Arizona
2003–2005

Clinical trials

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Principal investigator · Completed · Phase 3
Debiovision
2006–2008
MMF Influence on HCV Viral Evolution After Liver Transplantation
Principal investigator · Completed
Mayo Clinic
2002–2007
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2024–2030
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Site PI · Recruiting · Phase 3
Takeda
2024–2028

Honors

Fellow, American Society for Gastrointestinal Endoscopy
2019
American Society for Gastrointestinal Endoscopy
Fellow
2014
American Association for the Study of Liver Diseases
Fellow, American Gastroenterological Association
2006
American Gastroenterological Association
Fellow, American College of Gastroenterology
2005
American College of Gastroenterology
Fellow, American College of Physicians
2005
American College of Physicians

mayo.edu mayoclinic.org